Funder: Breakthrough T1D

Due Dates: October 29, 2025 (Letter of Intent) | January 13, 2026 (Full Proposal)

Funding Amounts: Up to $3,000,000 total for up to 3 years; budget commensurate with scope; 10% indirect costs for nonprofits.

Summary: Supports clinical trials to develop and advance therapies that reduce cardiovascular disease risk or complications in people with type 1 diabetes.

Key Information: LOI required before full proposal; both academic and industry applicants eligible; industry projects require matching funds.